JP2010517513A5 - - Google Patents

Info

Publication number

JP2010517513A5

JP2010517513A5 JP2009547285A JP2009547285A JP2010517513A5 JP 2010517513 A5 JP2010517513 A5 JP 2010517513A5 JP 2009547285 A JP2009547285 A JP 2009547285A JP 2009547285 A JP2009547285 A JP 2009547285A JP 2010517513 A5 JP2010517513 A5 JP 2010517513A5

Authority

JP

Japan

Prior art keywords

antibody

seq

human

isolated antibody

chain variable

Prior art date

2008-01-24

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001413 amino acids Chemical class 0.000 claims description 71
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 36
• 230000027455 binding Effects 0.000 claims description 36
• 229930195712 glutamate Natural products 0.000 claims description 36
• 238000000034 method Methods 0.000 claims description 36
• 239000003446 ligand Substances 0.000 claims description 35
• 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 claims description 24
• 102000005650 Notch Receptors Human genes 0.000 claims description 24
• 108010070047 Notch Receptors Proteins 0.000 claims description 24
• 229920001184 polypeptide Polymers 0.000 claims description 22
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 22
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
• 101000737793 Homo sapiens Cerebellar degeneration-related antigen 1 Proteins 0.000 claims description 12
• 101000978766 Homo sapiens Neurogenic locus notch homolog protein 1 Proteins 0.000 claims description 9
• 101000577199 Homo sapiens Neurogenic locus notch homolog protein 2 Proteins 0.000 claims description 9
• 101000577202 Homo sapiens Neurogenic locus notch homolog protein 3 Proteins 0.000 claims description 9
• 101000577163 Homo sapiens Neurogenic locus notch homolog protein 4 Proteins 0.000 claims description 9
• 102000045609 human NOTCH1 Human genes 0.000 claims description 9
• 102000046883 human NOTCH2 Human genes 0.000 claims description 9
• 102000047120 human NOTCH4 Human genes 0.000 claims description 9
• 102000040430 polynucleotide Human genes 0.000 claims description 9
• 108091033319 polynucleotide Proteins 0.000 claims description 9
• 239000002157 polynucleotide Substances 0.000 claims description 9
• 102000001760 Notch3 Receptor Human genes 0.000 claims description 6
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 5
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 5
• 206010028980 Neoplasm Diseases 0.000 claims description 4
• 239000005557 antagonist Substances 0.000 claims description 4
• 201000011510 cancer Diseases 0.000 claims description 4
• 238000004519 manufacturing process Methods 0.000 claims description 4
• 239000008194 pharmaceutical composition Substances 0.000 claims description 4
• 230000011664 signaling Effects 0.000 claims description 4
• 230000009870 specific binding Effects 0.000 claims description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
• 239000003814 drug Substances 0.000 claims description 3
• 229940124597 therapeutic agent Drugs 0.000 claims description 3
• 206010006187 Breast cancer Diseases 0.000 claims description 2
• 208000026310 Breast neoplasm Diseases 0.000 claims description 2
• 206010009944 Colon cancer Diseases 0.000 claims description 2
• 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
• 206010060862 Prostate cancer Diseases 0.000 claims description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
• 238000002648 combination therapy Methods 0.000 claims description 2
• 231100000433 cytotoxic Toxicity 0.000 claims description 2
• 230000001472 cytotoxic effect Effects 0.000 claims description 2
• 201000010536 head and neck cancer Diseases 0.000 claims description 2
• 208000014829 head and neck neoplasm Diseases 0.000 claims description 2
• 230000003053 immunization Effects 0.000 claims description 2
• 201000005202 lung cancer Diseases 0.000 claims description 2
• 208000020816 lung neoplasm Diseases 0.000 claims description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
• 201000002528 pancreatic cancer Diseases 0.000 claims description 2
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
• 238000004091 panning Methods 0.000 claims description 2
• 239000000427 antigen Substances 0.000 claims 1
• 102000036639 antigens Human genes 0.000 claims 1
• 108091007433 antigens Proteins 0.000 claims 1
• 108020001756 ligand binding domains Proteins 0.000 description 4
• 241000283984 Rodentia Species 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 210000004408 hybridoma Anatomy 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical group 0.000 description 2
• 229930012538 Paclitaxel Natural products 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 229960001592 paclitaxel Drugs 0.000 description 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1